Latest Security News

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Mithril Silver and Gold Limited has announced a C$10 million brokered private placement to fund expanded exploration at its Copalquin district project in Mexico. The raise includes an option for agents to increase the placement by 15%, underscoring strong investor interest.

Blackstone Minerals has completed a significant capital raise, issuing nearly 290 million new shares to bolster its financial position. The move follows regulatory compliance assurances and sets the stage for the company’s next growth phase.

Pantera Lithium Limited has agreed to sell its Smackover lithium brine project in Arkansas to Energy Exploration Technologies for A$40 million, combining cash and stock consideration while retaining equity exposure to the lithium sector.

Viridis Mining and Minerals has released a comprehensive Pre-Feasibility Study for its Colossus Rare Earth Project in Brazil, showcasing robust economics, low-cost production, and a clear path to production by 2028. The study highlights the project's resilience across price cycles and its strategic positioning in the global rare earth supply chain.

Almonty Industries has requested a voluntary suspension of its ASX-listed securities pending the release of an updated technical report on its Sangdong Project in South Korea. The suspension will last until trading resumes on 11 July or the announcement is made.

Netlinkz Limited has forged a strategic partnership with Kognitive Networks and Securelink Networks to enhance secure enterprise communication across Australia, New Zealand, and Southeast Asia using cutting-edge network management technology.

Anatara Lifesciences has strengthened its intellectual property portfolio with a Japanese patent for its GaRP gastrointestinal health product, while progressing pre-clinical studies in its Anti-Obesity Project. The company also confirmed registration of its R&D Tax Incentive application for 2024-2025.

Island Pharmaceuticals has accelerated its acquisition of the Galidesivir antiviral program from BioCryst Pharmaceuticals, adding a clinically advanced asset with significant US government backing and a promising regulatory pathway.

Sparc Technologies progresses its pioneering green hydrogen pilot plant and graphene-based coatings, backed by a significant government grant and a successful capital raise.

Native Mineral Resources has raised A$10 million through a share placement to fund the ramp-up of gold production at its Blackjack plant in Queensland, following its first gold pour ahead of schedule.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.